Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
IBB vs PBE
Shared holdings
24
IBB covered by PBE
33.24%
PBE covered by IBB
33.24%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
IBB (March 31, 2026)
| Security | Weight | |
|---|---|---|
| BlackRock Cash Funds: Institutional, SL Agency Shares | 8.81% | |
| GILEAD SCIENCES INC | 7.06% | |
| AMGEN INC | 6.84% | |
| VERTEX PHARMACEUTICALS INC | 6.79% | |
| REGENERON PHARMACEUTICALS INC | 6.58% | |
| ALNYLAM PHARMACEUTICALS INC | 3.64% | |
| INSMED INC | 2.91% | |
| ARGENX SE SPONSORED ADR | 2.80% | |
| BIOGEN INC | 2.25% | |
| NATERA INC | 2.20% | |
| UNITED THERAPEUTICS CORP DEL | 2.10% | |
| BEONE MEDICINES LTD ADR | 1.76% | |
| INCYTE CORP | 1.55% | |
| MODERNA INC | 1.54% | |
| ILLUMINA INC | 1.53% | |
| REVOLUTION MEDICINES INC | 1.40% | |
| ROIVANT SCIENCES LTD | 1.13% | |
| NEUROCRINE BIOSCIENCES INC | 1.08% | |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 1.07% | |
| BRIDGEBIO PHARMA INC | 1.03% | |
| IONIS PHARMACEUTICALS INC | 1.02% | |
| MEDPACE HOLDINGS INC | 0.92% | |
| MADRIGAL PHARMACEUTICALS INC | 0.91% | |
| EXELIXIS INC | 0.90% | |
| BIOMARIN PHARMACEUTICAL INC | 0.90% | |
| Ascendis Pharma A/S | 0.87% | |
| PRAXIS PRECISION MEDICINES INC | 0.71% | |
| CHARLES RIVER LABS INTL INC | 0.70% | |
| ARROWHEAD PHARMACEUTICALS INC | 0.69% | |
| VAXCYTE INC | 0.68% | |
| BIO-TECHNE CORP | 0.68% | |
| CYTOKINETICS INC | 0.66% | |
| HALOZYME THERAPEUTICS INC | 0.63% | |
| AXSOME THERAPEUTICS INC | 0.61% | |
| BIONTECH SE ADR | 0.60% | |
| KRYSTAL BIOTECH INC | 0.55% | |
| PROTAGONIST THERAPEUTICS INC | 0.53% | |
| REPLIGEN CORP | 0.52% | |
| KYMERA THERAPEUTICS INC | 0.49% | |
| ALKERMES PLC | 0.48% | |
| RHYTHM PHARMACEUTICALS INC | 0.46% | |
| Abivax SA SPONSORED ADS | 0.46% | |
| PTC THERAPEUTICS INC | 0.45% | |
| COGENT BIOSCIENCES INC | 0.44% | |
| ARCELLX INC | 0.43% | |
| TERNS PHARMACEUTICALS INC | 0.42% | |
| NUVALENT INC-A | 0.41% | |
| MIRUM PHARMACEUTICALS INC | 0.41% | |
| TEMPUS AI INC-A | 0.39% | |
| XENON PHARMACEUTICALS INC | 0.39% |
PBE (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| Invesco Private Prime Fund | 8.92% | |
| ILLUMINA INC | 4.98% | |
| GILEAD SCIENCES INC | 4.91% | |
| AMGEN INC | 4.43% | |
| BIOGEN INC | 4.40% | |
| UNITED THERAPEUTICS CORP DEL | 4.26% | |
| REGENERON PHARMACEUTICALS INC | 4.22% | |
| INCYTE CORP | 4.08% | |
| Invesco Private Government Fund | 3.43% | |
| AMICUS THERAPEUTICS INC | 3.41% | |
| ALNYLAM PHARMACEUTICALS INC | 3.37% | |
| DYNAVAX TECHNOLOGIES CORP | 3.20% | |
| QIAGEN NV ORD SHARES | 2.68% | |
| MANNKIND CORP | 2.66% | |
| IONIS PHARMACEUTICALS INC | 2.49% | |
| ACADIA PHARMACEUTICALS INC | 2.48% | |
| ROYALTY PHARMA-A | 2.48% | |
| CATALYST PHARMACEUTICALS INC | 2.44% | |
| BIOMARIN PHARMACEUTICAL INC | 2.41% | |
| BIO-TECHNE CORP | 2.38% | |
| COLLEGIUM PHARMACEUTICAL INC | 2.38% | |
| EXELIXIS INC | 2.31% | |
| HALOZYME THERAPEUTICS INC | 2.29% | |
| BIOCRYST PHARMACEUTICALS INC | 2.27% | |
| NEUROCRINE BIOSCIENCES INC | 2.27% | |
| PTC THERAPEUTICS INC | 2.23% | |
| PROTAGONIST THERAPEUTICS INC | 2.20% | |
| VERICEL CORP | 2.19% | |
| TG THERAPEUTICS INC | 2.17% | |
| REPLIGEN CORP | 2.11% | |
| MADRIGAL PHARMACEUTICALS INC | 1.97% | |
| VERACYTE INC | 1.93% | |
| Invesco Government & Agency Portfolio, Institutional Class | 0.06% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.